High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease. Tay WL, Chng CL, Tien CS, Loke KS, Lam WW, Fook-Chong SM, Tong AK. Ann Acad Med Singapore, Jun 2019; 48 (6): 181-187
Myoepithelial hyperplasia: A rare mimic of breast cancer on 18F-FDG PET/CT. Tang CYL, Lam WW, Tan PH, Xie W, Peh WM, Tan VK, Leong LCH. Breast J, Apr 2020; 26(4), 775-77
Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020? Lam WWC, Loke KSH, Wong WY, Ng DCE. Eur J Nucl Med Mol Imaging, Jul 2020; 47 (7): 1645-1648
Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer - a prospective pilot study in an Asian population. Thang SP, Lam WWC, Tong AKT, Allen JCJ, Ler ASL, Tay YS, Somanesan S, Kanesvaran R, Wong ASC, Ng DCE. Nucl Med Commun, Jul 2020; 41 (7): 618-628
Divide and Conquer: Strategies to Manage a Nuclear Medicine Department During COVID-19. Tham WY, Tong AKT, Loke KSH, Chio LY, Lim GKY, Seah XY, Ng DCE, Yan SXX, Lam WW. J Nucl Med Technol, 2020; 48(2): 98-101
Safeguarding children from coronavirus disease 2019: Practices of nuclear medicine units in Singapore. Cheng LTJ, Peh WM, Lam WWC. Proceedings of Singapore Healthcare, 2021; 30 (1): 36-40
18F-FDG PET/CT Manifestations of IgG4-related Disease. Tang CYL, Chua WM, Cheng LTJ, Fong W, Zaheer S, Lam WW. Br J Radiol, 2021; 94 (1124): 20210105
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method. Ng DZ, Lee CY, Lam WW, Tong AK, Tan SH, Khoo LP, Tan YH, Chiang J, Chang ES, Chan JY, Poon EY, Somasundaram N, Rashid MFH, Tao M, Lim ST, Yang VS. Leukemia & Lymphoma, 2022, 63 (1):256-259
Optimization of Bayesian penalized likelihood reconstruction for 68Ga-prostate-specific membrane antigen-11 PET/computed tomography. Tang CYL, Lim GKY, Chua WM, Ng CWQ, Koo SX, Goh CX, Thang SP, Zaheer S, Lam WWC, Huang HL. Nucl Med Commun, 2023, 44
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response. Chen M, Tang CYL, Fong WWS, Lam WW. EJNMMI Res, 2023, 13(1): 22
Outcomes and prognostic predictors of Lu‐177 PSMA radioligand therapy in metastatic castration‐resistant prostate cancer (Asian Population Study). Chua WM, Lam WW-C, Tong AK-T, Sultana R, Kua SMY, Kanesvaran R, Wong ASC, Tay KJ, Cheng TJL, Ng DCE, Thang SP. Asia Pac J Clin Oncol, 2023; 1-10
Radiolabeled Liposomes for Nuclear Imaging Probes. Low HY, Yang C, Xia B, He T, Lam WWC, Ng DCE. Molecules, 2023, 28(9): 3798
18F-FMISO PET-guided dose escalation with multifield optimization intensity-modulated proton therapy in nasopharyngeal carcinoma. Sommat K, Tong AKT, Ong ALK, Hu J, Sin SY, Lam WWC, Xie W, Khor YM, Lim C, Lim TW, Selvarajan S, Wang F, Tan TWK, Wee JTS, Soong YL, Fong KW, Hennedige, T, Thng CH. Asia Pac J Clin Oncol, 2023; https://imsva91-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fdoi.org%2f10.1111%2fajco.13953&umid=EBC76FA7-00CD-5506-8DDF-BFDDDD534D13&auth=6e3fe59570831a389716849e93b5d483c90c3fe4-760e899c923d8da0fa31d7c3e5c50462d18e10b3
Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis. Chow KM, So WZ, Lee HJ, Lee A, Yap DWT, Takwoingi Y, Tay KJ, Tuan J, Thang SP, Lam W, Yuen J, Lawrentschuk N, Hofman MS, Murphy DG, Chen K. European Urology, 2023